Aprepitant for severe refractory pruritus in a patient with relapsed Hodgkin lymphoma
Pediatric Blood & Cancer · 2024-03 · 71 (3)
DOI: 10.1002/pbc.30826 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 25.12.2023. Verfasst von Anwar Al Nassan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, King Hussein Cancer Center, Amman, Jordan. Hauptthemen laut MEDLINE: Hodgkin Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, King Hussein Cancer Center, Amman, Jordan.
- Department of Pediatrics, Jordan University Hospital, Amman, Jordan.
- Artificial Intelligence and Data Innovation Office, King Hussein Cancer Center, Amman, Jordan.
ORCID-Profile: Anwar Al Nassan, Iyad Sultan
Zitieren
APA
Al Nassan, A., Bazzeh, F., & Sultan, I. (2024). Aprepitant for severe refractory pruritus in a patient with relapsed Hodgkin lymphoma. Pediatric Blood & Cancer, 71(3). https://doi.org/10.1002/pbc.30826
Vancouver
Al Nassan A, Bazzeh F, Sultan I. Aprepitant for severe refractory pruritus in a patient with relapsed Hodgkin lymphoma. Pediatric Blood & Cancer. 2024;71(3). doi:10.1002/pbc.30826
BibTeX
@article{AlNassan2024,
author = {Al Nassan, Anwar and Bazzeh, Faiha and Sultan, Iyad},
title = {Aprepitant for severe refractory pruritus in a patient with relapsed Hodgkin lymphoma},
journal = {Pediatric Blood & Cancer},
year = {2024},
volume = {71},
number = {3},
doi = {10.1002/pbc.30826}
}
EUVIMED